Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Antoine Ezhaya is active.

Publication


Featured researches published by Antoine Ezhaya.


Tetrahedron Letters | 2001

Solid-phase synthesis of 3-hydroxymethyl isoxazoles via resin bound nitrile oxides

Enzo Cereda; Antoine Ezhaya; Monica Quai; Walter Barbaglia

Abstract [3+2] Cycloaddition of alkynes to resin bound nitrile oxides gives after cleavage of 3,4,5 trisubstituted isoxazoles in acceptable yields and fair to good purity, depending on the alkyne substituents. The reaction has been automated on the ACT 496 synthesiser.


European Journal of Medicinal Chemistry | 1987

Anti-secretory and anti-ulcer activities of some new 2-(2-pyridylmethyl-sulfinyl)-benzimidazoles

Enzo Cereda; Marco Turconi; Antoine Ezhaya; Elio Bellora; Alessandro Brambilla; Ferdinando Pagani; Arturo Donetti

Abstract A series of substituted sulfinyl benzimidazoles were prepared and tested for gastric anti-secretory activity. Following initial screening, two compounds were tested for anti-ulcer activity. The new compounds showed pharmacological properties different from those of omeprazole 1 , since they proved to be weak anti-secretory agents displaying non-specific anti-ulcer activity. Some structural requirements for optimum activity were elucidated.


European Journal of Medicinal Chemistry | 1994

New pyrrolidin-, piperidin- and azepin-2-oxocarboxylic acid esters are preferential M1, M3 muscarinic antagonists. Synthesis and bronchospasmolytic activity

Enzo Cereda; Antoine Ezhaya; Elio Bellora; Giovanni Battista Schiavi; Angelo Sagrada; Hn Doods; Arturo Donetti

A series of new 3-tropanol and 3-quinuclidinol esters of phenyl-substituted pyrrolidin-, piperidin- and azepin-2-oxocarboxylic acid were synthesized and tested for antimuscarinic activity. The compounds showed a preferential in vitro activity at M1 and M3 receptor subtypes and an interesting activity profile in vivo. A potential use as selective bronchospasmolytic agents has been suggested for selected compounds.


Archive | 2006

Stable polymorph of flibanserin

Carlo Bombarda; Enrica Dubini; Antoine Ezhaya; Heinrich Schneider


Archive | 2005

Use of a polymorph of flibanserin for treating disease

Carlo Bombarda; Enrica Dubini; Antoine Ezhaya


Journal of Medicinal Chemistry | 1990

Synthesis and biological evaluation of new antimuscarinic compounds with amidine basic centers a useful bioisosteric replacement of classical cationic heads

Enzo Cereda; Antoine Ezhaya; Myrna Gil Quintero; Elio Bellora; Enrica Dubini; Rosella Micheletti; Antonio Schiavone; Alessandro Brambilla; Giovanni Battista Schiavi; Arturo Donetti


Archive | 2002

Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments

Carlo Bombarda; Enrica Dubini; Antoine Ezhaya


Journal of Medicinal Chemistry | 1989

N-(Fluoroethyl)(imidazolylphenyl)formamidines. The issue of the active species of mifentidine

Arturo Donetti; Enzo Cereda; Antoine Ezhaya; Rosella Micheletti


Archive | 1994

Crystalline forms of endo-2,3-dihydro-N-(8-methyl)-8-azabicyclo[3.2.1]oct-3-yl)-2-oxo-1H-benzimidazole-1-carboxamides

Enzo Cereda; Antoine Ezhaya; Marco Turconi; Enrica Dubini; Grazia Maffione


Archive | 2005

POLIMORFO ESTAVEL DA FLIBANSERINA, PROCESSO TECNICO PARA A SUA PREPARACAO E SUA UTILIZACAO NA PREPARACAO DE MEDICAMENTOS

Dubini Enrica; Carlo Bombarda; Antoine Ezhaya

Collaboration


Dive into the Antoine Ezhaya's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge